Sunday 11 October 2026
Export all OHI data to Excel Powerpack
Omega Healthcare Investors, Inc.
OHI Real Estate Reit Healthcare Facilities
Omega Healthcare Investors, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, up 13.2% from fiscal 2024. In the quarter to June 2026, revenue grew 16.2%, EPS grew 163.0%, free cash flow grew 710.6% and total debt fell 99.9%, each against the same quarter a year earlier. Dividend growth for ten consecutive years, revenue growth for three; insiders bought in the last twelve months.
44.41
0.27
+0.61%
Follow OHI
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
16.85 | 21.07 | 22.74 | 23.33 |
+8 more quarters Free account |
P/S ratio |
11.11 | 10.53 | 10.87 | 10.86 | |
P/FCF ratio |
17.12 | 184.85 | 159.52 | 80.73 | |
P/Operating CF |
65.45 | 60.40 | 56.07 | 55.09 | |
P/B ratio |
2.53 | 2.39 | 2.38 | 2.38 | |
Price to Tangible BV |
2.85 | 2.71 | 2.70 | 2.72 | |
EV/Sales |
10.98 | 14.08 | 11.02 | 14.53 | |
EV/EBITDA |
12.45 | 15.81 | 12.57 | 16.37 | |
EV/Operating CF |
15.80 | 19.08 | 14.93 | 19.06 | |
EV/FCF |
16.91 | 247.17 | 161.84 | 108.00 | |
Quick Ratio |
2.10 | 1.21 | 1.89 | 3.15 | |
Current Ratio |
6.03 | 5.32 | 5.81 | 7.11 | |
Net Debt/EBITDA |
(0.62) | 15.68 | 0.68 | 14.67 | |
Debt/Assets |
0.06% | 43.40% | 2.41% | 47.14% | |
Debt/Equity |
0.00 | 0.81 | 0.04 | 0.95 | |
Asset Turnover |
0.12 | 0.12 | 0.12 | 0.11 | |
Operating CF/Net income |
0.58 | 1.47 | 1.35 | 1.24 | |
Capex/Depreciation |
4.44 | (1.85) | (4.34) | (0.11) | |
Interest Coverage |
3.92 | 4.13 | 3.78 | 3.52 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
12.79% | 8.06% | 7.83% | 7.63% | |
Intangible Assets out of Total Assets |
0.06 | 0.06 | 0.06 | 0.06 | |
Share Based Compensation of Revenue |
7.14% | 3.28% | 3.09% | 2.98% | |
Graham Net Nets |
(0.16) | (0.23) | (0.20) | (0.22) | |
Graham Number |
34.67 | 29.32 | 28.61 | 26.87 | |
Earnings Yield |
5.94% | 4.75% | 4.40% | 4.29% | |
Free Cash Flow Yield |
5.84% | 0.54% | 0.63% | 1.24% | |
Revenue per Share |
1.10 | 1.09 | 1.09 | 1.05 | |
Operating CF per Share |
0.73 | 0.73 | 0.79 | 0.77 | |
Capex per Share |
1.46 | (0.46) | (1.19) | (0.03) | |
Free Cash Flow per Share |
2.19 | 0.26 | (0.40) | 0.73 | |
Cash per Share |
0.62 | 0.18 | 0.19 | 2.62 | |
Shareholders Equity per Share |
18.88 | 18.36 | 18.65 | 17.73 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
18.88 | 18.36 | 18.65 | 17.73 | |
Free Cash Flow |
654.61 | 77.69 | (117.43) | 217.38 | |
Working Capital |
1,749.35 | 1,459.70 | 1,694.06 | 2,185.08 | |
Capital Expenditures |
436.89 | (137.82) | (348.05) | (9.34) | |
Net Current Asset Value |
(2,275.26) | (2,981.59) | (2,561.95) | (2,809.46) | |
EV/EBIT |
17.72 | 22.63 | 18.29 | 24.06 | |
Capex to Sales |
(1.33) | 0.43 | 1.09 | 0.03 | |
Price to Operating Income |
17.94 | 16.93 | 18.03 | 17.99 | |
| Other line items | |||||
Average Receivables |
445.58 | 349.32 | 477.99 | 349.15 | |
Average Assets |
10,280.62 | 9,970.14 | 9,973.48 | 10,083.94 | |
Average Common Equity |
5,415.65 | 5,193.52 | 5,085.67 | 4,822.18 |
Columns are period end dates